Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo. [Phase 3]

View source ↗

Summary

Phase 3 trial results assessing the efficacy and safety of secukinumab versus placebo in Chinese patients with active psoriatic arthritis; results were posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2024-07-19